Table of Content

1. Executive Summary
1.1. Global Cell Line Development Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Cell Line Development Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Application Landscape
3. Global Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Cell Line Development Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Immunotherapy Cell Lines
3.3.3.2. GPCR Cell Lines
3.3.3.3. Cell Signaling Pathway Cell Lines
3.3.3.4. Gene Knockout Cell Lines
3.3.3.5. Ion Channel Cell Lines
3.3.3.6. Cancer Cell Lines
3.3.3.7. Others
3.4. Market Attractiveness Analysis: Product
3.5. Global Cell Line Development Market Outlook: Application
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.5.3.1. Drug Discovery & Development
3.5.3.2. Basic Research
3.5.3.3. Toxicity Screening
3.5.3.4. Biopharmaceutical Production
3.5.3.5. Tissue Engineering
3.5.3.6. Forensic Testing
3.6. Market Attractiveness Analysis: Application
3.7. Global Cell Line Development Market Outlook: End-User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
3.7.3.1. Biopharmaceutical Companies
3.7.3.2. Contract Research Organization
3.7.3.3. Academic & Research Institutes
3.7.3.4. Forensic Science Laboratories
3.7.3.5. Diagnostic Laboratories
3.8. Market Attractiveness Analysis: End-User
4. Global Cell Line Development Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By Application
5.3.4. By End-User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Immunotherapy Cell Lines
5.5.2. GPCR Cell Lines
5.5.3. Cell Signaling Pathway Cell Lines
5.5.4. Gene Knockout Cell Lines
5.5.5. Ion Channel Cell Lines
5.5.6. Cancer Cell Lines
5.5.7. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.6.1. Drug Discovery & Development
5.6.2. Basic Research
5.6.3. Toxicity Screening
5.6.4. Biopharmaceutical Production
5.6.5. Tissue Engineering
5.6.6. Forensic Testing
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
5.7.1. Biopharmaceutical Companies
5.7.2. Contract Research Organization
5.7.3. Academic & Research Institutes
5.7.4. Forensic Science Laboratories
5.7.5. Diagnostic Laboratories
5.8. Market Attractiveness Analysis
6. Europe Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Application
6.3.4. By End-User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Immunotherapy Cell Lines
6.5.2. GPCR Cell Lines
6.5.3. Cell Signaling Pathway Cell Lines
6.5.4. Gene Knockout Cell Lines
6.5.5. Ion Channel Cell Lines
6.5.6. Cancer Cell Lines
6.5.7. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.6.1. Drug Discovery & Development
6.6.2. Basic Research
6.6.3. Toxicity Screening
6.6.4. Biopharmaceutical Production
6.6.5. Tissue Engineering
6.6.6. Forensic Testing
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
6.7.1. Biopharmaceutical Companies
6.7.2. Contract Research Organization
6.7.3. Academic & Research Institutes
6.7.4. Forensic Science Laboratories
6.7.5. Diagnostic Laboratories
6.8. Market Attractiveness Analysis
7. East Asia Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By Application
7.3.4. By End-User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Immunotherapy Cell Lines
7.5.2. GPCR Cell Lines
7.5.3. Cell Signaling Pathway Cell Lines
7.5.4. Gene Knockout Cell Lines
7.5.5. Ion Channel Cell Lines
7.5.6. Cancer Cell Lines
7.5.7. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.6.1. Drug Discovery & Development
7.6.2. Basic Research
7.6.3. Toxicity Screening
7.6.4. Biopharmaceutical Production
7.6.5. Tissue Engineering
7.6.6. Forensic Testing
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
7.7.1. Biopharmaceutical Companies
7.7.2. Contract Research Organization
7.7.3. Academic & Research Institutes
7.7.4. Forensic Science Laboratories
7.7.5. Diagnostic Laboratories
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By Application
8.3.4. By End-User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Immunotherapy Cell Lines
8.5.2. GPCR Cell Lines
8.5.3. Cell Signaling Pathway Cell Lines
8.5.4. Gene Knockout Cell Lines
8.5.5. Ion Channel Cell Lines
8.5.6. Cancer Cell Lines
8.5.7. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.6.1. Drug Discovery & Development
8.6.2. Basic Research
8.6.3. Toxicity Screening
8.6.4. Biopharmaceutical Production
8.6.5. Tissue Engineering
8.6.6. Forensic Testing
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
8.7.1. Biopharmaceutical Companies
8.7.2. Contract Research Organization
8.7.3. Academic & Research Institutes
8.7.4. Forensic Science Laboratories
8.7.5. Diagnostic Laboratories
8.8. Market Attractiveness Analysis
9. Latin America Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End-User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Immunotherapy Cell Lines
9.5.2. GPCR Cell Lines
9.5.3. Cell Signaling Pathway Cell Lines
9.5.4. Gene Knockout Cell Lines
9.5.5. Ion Channel Cell Lines
9.5.6. Cancer Cell Lines
9.5.7. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.6.1. Drug Discovery & Development
9.6.2. Basic Research
9.6.3. Toxicity Screening
9.6.4. Biopharmaceutical Production
9.6.5. Tissue Engineering
9.6.6. Forensic Testing
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
9.7.1. Biopharmaceutical Companies
9.7.2. Contract Research Organization
9.7.3. Academic & Research Institutes
9.7.4. Forensic Science Laboratories
9.7.5. Diagnostic Laboratories
9.8. Market Attractiveness Analysis
10. Middle East & Africa Cell Line Development Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End-User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Immunotherapy Cell Lines
10.5.2. GPCR Cell Lines
10.5.3. Cell Signaling Pathway Cell Lines
10.5.4. Gene Knockout Cell Lines
10.5.5. Ion Channel Cell Lines
10.5.6. Cancer Cell Lines
10.5.7. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.6.1. Drug Discovery & Development
10.6.2. Basic Research
10.6.3. Toxicity Screening
10.6.4. Biopharmaceutical Production
10.6.5. Tissue Engineering
10.6.6. Forensic Testing
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
10.7.1. Biopharmaceutical Companies
10.7.2. Contract Research Organization
10.7.3. Academic & Research Institutes
10.7.4. Forensic Science Laboratories
10.7.5. Diagnostic Laboratories
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition GPCR Cell Lines
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. BPS Bioscience, Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Thermo Fisher Scientific Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. ATCC (American Type Culture Collection)
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Sigma-Aldrich (Merck Group Company)
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Lonza
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. STEMCELL Technologies
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. BioIVT LLC
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Novus Biologicals
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Rockland Immunochemicals
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. GenScript
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. BiologicsCorp
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Horizon Discovery
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Synthego
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
11.3.14. AcceGen
11.3.14.1. Overview
11.3.14.2. Segments and Product
11.3.14.3. Key Financials
11.3.14.4. Market Developments
11.3.14.5. Market Strategy
11.3.15. Promega
11.3.15.1. Overview
11.3.15.2. Segments and Product
11.3.15.3. Key Financials
11.3.15.4. Market Developments
11.3.15.5. Market Strategy
11.3.16. FenicsBIO
11.3.16.1. Overview
11.3.16.2. Segments and Product
11.3.16.3. Key Financials
11.3.16.4. Market Developments
11.3.16.5. Market Strategy
11.3.17. InvivoGen
11.3.17.1. Overview
11.3.17.2. Segments and Product
11.3.17.3. Key Financials
11.3.17.4. Market Developments
11.3.17.5. Market Strategy
11.3.18. Abcam plc.
11.3.18.1. Overview
11.3.18.2. Segments and Product
11.3.18.3. Key Financials
11.3.18.4. Market Developments
11.3.18.5. Market Strategy
11.3.19. Eurofins DiscoverX.
11.3.19.1. Overview
11.3.19.2. Segments and Product
11.3.19.3. Key Financials
11.3.19.4. Market Developments
11.3.19.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations